Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial (2022)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- DOI: 10.1016/j.ahj.2021.12.010
- Subjects: COVID-19; TROMBOSE; REPLICAÇÃO VIRAL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: American heart journal
- ISSN: 0002-8703
- Volume/Número/Paginação/Ano: v. 246, p. 136-143, 2022
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
HESS, Connie N. et al. Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial. American heart journal, v. 246, p. 136-143, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2021.12.010. Acesso em: 01 jun. 2024. -
APA
Hess, C. N., Capell, W. H., Bristow, M. R., Ruf, W., Szarek, M., Morrow, D. A., et al. (2022). Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial. American heart journal, 246, 136-143. doi:10.1016/j.ahj.2021.12.010 -
NLM
Hess CN, Capell WH, Bristow MR, Ruf W, Szarek M, Morrow DA, Nicolau JC, Graybill CA, Marshall D, Hsia J. Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial [Internet]. American heart journal. 2022 ; 246 136-143.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.ahj.2021.12.010 -
Vancouver
Hess CN, Capell WH, Bristow MR, Ruf W, Szarek M, Morrow DA, Nicolau JC, Graybill CA, Marshall D, Hsia J. Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial [Internet]. American heart journal. 2022 ; 246 136-143.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.ahj.2021.12.010 - Síndrome coronariana aguda com elevação do segmento St: tratamento medicamentoso
- Isquemia miocárdica como manifestação inicial de arterite de Takaysu
- Prasugrel, ticagrelor e antagonista do receptor da trombina nas síndromes isquêmicas miocárdicas instáveis com e sem supradesnível do segmento ST
- Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes: The TAO Randomized Clinical Trial
- Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease
- Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI-38 Coronary Stent Registry
- Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States
- Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy
- Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial
- Urgent revascularization strategies in patients with diabetes mellitus and acute coronary syndrome
Informações sobre o DOI: 10.1016/j.ahj.2021.12.010 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas